Senate bill · 119th Congress · Latest step: Introduced
Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025
Official title: A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for reciprocal marketing approval of certain drugs, biological products, and devices that are authorized to be lawfully marketed abroad, and for other purposes.
Sponsor: Sen. Ted Cruz R-TXWhere it went
- IntroducedOct 30, 2025
- Committee action—
- Passed Senate—
- Passed House—
- To the President—
- Became law—
Latest action: Oct 30, 2025 — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Vote results
No recorded roll-call votes on this bill in PORKER’s records (voice votes and unanimous consent are not roll calls; roll-call records start in 2011).
Cosponsors
1 cosponsor — 1 Republican
0 of 1 cosponsors (0%) are from the other party.
More from the sponsor
Other 119th Congress bills sponsored by Sen. Ted Cruz.
Related bills
- H.R. 1632 (119th) Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025Identical bill
Relationships as recorded by Congress.gov.
Sponsor’s state and district
Data as of Sep 13, 2026 · bill record checked by PORKER from Congress.gov · votes from Senate.gov and the House Clerk. PORKER is non-partisan.